Marcos de Lima, MD

Showing    of 4 results

Vanquishing Viruses

First-in-the-nation trial will use technology to target opportunistic infections Innovations in Cancer - Winter 2017 - View Full PDF  Marcos de Lima, MD Opportunistic viral infections remain a significant risk after hematopoietic stem cell...

Diagnosing Dysfunction

Innovations in Cancer - Summer 2016 - View Full PDF As a treatment for acute myeloid leukemia (AML), natural killer (NK) cells show encouraging potential. Because these cells are highly active in killing cancer, researchers have focused on...

Improving the Odds

Trial-focused SCT Program at UH Seidman Cancer Center looks to boost cure rates for hematologic malignancies  Innovations in Cancer - Winter 2016 Download PDF Marcos de Lima, MD After stem cell transplant (SCT), cure rates for hematologic...

A Paradigm Shift for Improving Hematologic Malignancy Outcomes in Adults

Oncology - January 2016    Marcos de Lima, MD Stem Cell Transplant Director Marcos de Lima, MD, new to UH Seidman Cancer Center from M.D. Anderson Cancer Center, has shown that injecting combined human cord blood cells and mesenchymal stromal...

Results are loading...
Back to Top